The Warnings and Precautions sections for healthcare professionals for Mounjaro and Trulicity were updated to notify doctors that Events related to impaired gastric emptying, including severe gastroparesis, have been reported and to Monitor and consider dose modification or discontinuation in patients who develop severe gastrointestinal symptoms while on treatment . The Patient Medical Information for both drugs was also updated to add language to alert users that Stomach problems, sometimes severe, have been reported in people who use the drugs and that patients should Tell your healthcare provider if you have stomach problems that are severe or will not go away. Siskinds is assisting Canadians who have been harmed by GLP-1 drugs Siskinds is seeking to recover compensation for Canadians suffering severe stomach issues and other serious health issues resulting from their use of prescription GLP-1 drugs, such as Ozempic, Rybelsus, Wegovy, Trulicity, and Mounjaro
In the Yale study, the most commonly reported issues were nausea, diarrhea, vomiting, and constipation
Its easier for patients to be consistent, and we know we need consistency to see results, she explains
Pilar Valdecantos
Phentermine/topiramate, while offering potential benefit as an adjunct, is limited by its adverse effect profile
This allows patients to understand coverage, costs, and treatment options before starting a medically supervised weight loss program
